Edwards Lifesciences
1,290 hedge funds and large institutions have $40.4B invested in Edwards Lifesciences in 2026 Q1 according to their latest regulatory filings, with 113 funds opening new positions, 457 increasing their positions, 458 reducing their positions, and 119 closing their positions.
0.53% more ownership
Funds ownership: 86.96% → 87.49% (+0.53%)
0% less repeat investments, than reductions
Existing positions increased: 457 | Existing positions reduced: 458
5% less first-time investments, than exits
New positions opened: 113 | Existing positions closed: 119
2% less funds holding
Funds holding: 1,314 → 1,290 (-24)
6% less capital invested
Capital invested by funds: $43B → $40.4B (-$2.64B)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
34% less call options, than puts
Call options by funds: $146M | Put options by funds: $223M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$419M |
| 2 |
Ninety One (UK)
London,
United Kingdom
|
+$384M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$333M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$182M |
| 5 |
Neuberger Berman Group
New York
|
+$167M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$353M |
| 2 |
JP Morgan Chase
New York
|
-$353M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$324M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$171M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$139M |
EW Hedge Fund Activity: Q1 2026 in Review
1,290 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q1 2026, worth a combined $40.4B — down 6.1% from $43B a quarter earlier.
Sellers outnumbered buyers: 119 funds closed out of EW and 113 opened new positions — a net loss of 6 holders — while 458 trimmed existing stakes and 457 added.
The largest buyer was DZ Bank, adding an estimated $419M. The largest seller was Millennium Management, cutting an estimated $353M.
- 1,290 institutional investors held Edwards Lifesciences (EW) as of Q1 2026, down from 1,314 in Q4 2025.
- Funds reported $40.4B of Edwards Lifesciences stock for Q1 2026, down 6.1% quarter-over-quarter.
- 113 funds opened new Edwards Lifesciences positions in Q1 2026 and 119 closed out, a net change of -6 holders.
- The largest Edwards Lifesciences buyer in Q1 2026 was DZ Bank, an estimated $419M added.
- The largest Edwards Lifesciences seller in Q1 2026 was Millennium Management, an estimated $353M sold.
Based on aggregated 13F filings for Q1 2026.